Paper Details 
Original Abstract of the Article :
<b>Objectives:</b> Cyproheptadine is a first-generation H1-antihistamine drug first that was distributed in the 1960s. While its orexigenic effect was observed early, cyproheptadine is not yet authorized for this indication in all countries today. There is an increasing medical interest and demand ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525494/

データ提供:米国国立医学図書館(NLM)

Cyproheptadine: A Journey Through the Desert of Drug Safety

Cyproheptadine, a first-generation H1-antihistamine, has been used for decades to treat allergies and, more recently, has gained attention for its orexigenic (appetite-stimulating) effects. This study, like a team of researchers carefully examining a seemingly familiar landscape, dives into the safety profile of cyproheptadine, considering its potential use as an appetite stimulant, particularly in children.

The authors, with the meticulousness of a desert archaeologist uncovering hidden secrets, analyzed data from the French national pharmacovigilance database and conducted a comprehensive review of the literature. Their objective was to assess the safety profile of cyproheptadine, considering its potential use as an appetite stimulant, particularly in children. Their findings provide valuable insights into the risks and benefits of this drug.

Navigating the Landscape of Drug Safety: A Balanced Approach

The study reveals that cyproheptadine, while generally considered safe, can cause mild neurological effects, particularly drowsiness, and rare but potentially serious hepatic complications. The researchers emphasize the importance of careful monitoring for potential liver toxicity and the need for further research to determine the safety and efficacy of cyproheptadine as an appetite stimulant, particularly in children.

A Prescription for Caution: Weighing Risks and Benefits

This study, like a desert oasis offering both respite and warning, highlights the importance of a balanced approach to cyproheptadine use. While it can be a valuable tool for treating allergies, its potential for liver toxicity and the lack of robust evidence for its efficacy as an appetite stimulant, particularly in children, warrant caution. It's essential to consult with a qualified healthcare professional to determine the appropriateness of cyproheptadine treatment and to carefully monitor for any adverse effects.

Dr. Camel's Conclusion

This study, like a reminder of the unpredictable nature of the desert, emphasizes the importance of ongoing vigilance in monitoring drug safety. While cyproheptadine offers potential benefits, its use should be approached with caution, particularly in children. Further research is needed to fully understand its safety and efficacy as an appetite stimulant.

Date :
  1. Date Completed n.d.
  2. Date Revised 2021-10-23
Further Info :

Pubmed ID

34676184

DOI: Digital Object Identifier

PMC8525494

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.